Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 50 of 134

1.

Correction: An Unusual Finding of a Ladybug on Screening Colonoscopy.

Tahan V, Tran KD, Yousef MA, Dailey FE, Uraz S.

ACG Case Rep J. 2019 Oct 17;6(10):e00270. doi: 10.14309/crj.0000000000000270. eCollection 2019 Oct.

2.

An Unusual Finding of a Ladybug on Screening Colonoscopy.

Tahan V, Tran KD, Yousef MA, Dailey FE, Uraz S.

ACG Case Rep J. 2019 Aug 15;6(8):e00174. doi: 10.14309/crj.0000000000000174. eCollection 2019 Aug. No abstract available. Erratum in: ACG Case Rep J. 2019 Oct 17;6(10):e00270.

3.

Factors associated with diverticular bleeding and re-bleeding: A United States hospital study.

Jalil AA, Gorski R, Jalil SA, Cronin R, Comianos M, Mann M, Rajagopalan H, Jalil AA, Tahan V.

North Clin Istanb. 2018 Sep 5;6(3):248-253. doi: 10.14744/nci.2018.23540. eCollection 2019.

4.

The dirty aspects of fecal microbiota transplantation: a review of its adverse effects and complications.

Dailey FE, Turse EP, Daglilar E, Tahan V.

Curr Opin Pharmacol. 2019 Dec;49:29-33. doi: 10.1016/j.coph.2019.04.008. Epub 2019 May 16. Review.

PMID:
31103793
5.

Fecal microbiota transplantation donation: the gift that keeps on giving.

Turse EP, Dailey FE, Ghouri YA, Tahan V.

Curr Opin Pharmacol. 2019 Dec;49:24-28. doi: 10.1016/j.coph.2019.04.009. Epub 2019 May 11. Review.

PMID:
31085417
6.

Clostridium Difficile Infection in Inflammatory Bowel Disease Patients.

Albarrak AA, Romana BS, Uraz S, Yousef MH, Juboori AA, Tahan V.

Endocr Metab Immune Disord Drug Targets. 2019;19(7):929-935. doi: 10.2174/1871530319666190301120558.

PMID:
30827274
7.

Interventions to improve sarcopenia in cirrhosis: A systematic review.

Naseer M, Turse EP, Syed A, Dailey FE, Zatreh M, Tahan V.

World J Clin Cases. 2019 Jan 26;7(2):156-170. doi: 10.12998/wjcc.v7.i2.156.

8.

Infliximab use in ulcerative colitis flare with clostridium difficile infection: A report of two cases and literature review.

Romana BS, Albarrak AA, Yousef MH, Tahan V.

North Clin Istanb. 2018 Sep;5(3):256-260. doi: 10.14744/nci.2017.79446.

9.

Stem cells for luminal, fistulizing, and perianal inflammatory bowel disease: a comprehensive updated review of the literature.

Turse EP, Dailey FE, Naseer M, Partyka EK, Bragg JD, Tahan V.

Stem Cells Cloning. 2018 Nov 27;11:95-113. doi: 10.2147/SCCAA.S135414. eCollection 2018. Review.

10.

One more chance of fistula healing in inflammatory bowel disease: Stem cell therapy.

Turse EP, Dailey FE, Naseer M, Partyka EK, Tahan V.

World J Clin Cases. 2018 Oct 26;6(12):493-500. doi: 10.12998/wjcc.v6.i12.493. Review.

11.

Probiotics for Gastrointestinal and Liver Diseases: An Updated Review of the Published Literature.

Dailey FE, Turse EP, Rossow B, Kuwajima VK, Tahan V.

Endocr Metab Immune Disord Drug Targets. 2019;19(5):549-570. doi: 10.2174/1871530318666181022163944. Review.

PMID:
30360751
12.

Extra-thoracic Extrinsic Compression: An Unusual Cause of Dysphagia.

Rao SC, Sathyamurthy A, Turse EP, Dailey FD, Tahan V.

Endocr Metab Immune Disord Drug Targets. 2019;19(2):230-231. doi: 10.2174/1871530318666181005101145.

PMID:
30289083
13.

Review of stem cells as promising therapy for perianal disease in inflammatory bowel disease.

Dailey FE, Turse EP, Naseer M, Bragg JD, Tahan V.

World J Transplant. 2018 Aug 9;8(4):97-101. doi: 10.5500/wjt.v8.i4.97. Review.

14.

Fecal microbiota transplantation and its potential therapeutic uses in gastrointestinal disorders.

Heath RD, Cockerell C, Mankoo R, Ibdah JA, Tahan V.

North Clin Istanb. 2018 Feb 12;5(1):79-88. doi: 10.14744/nci.2017.10692. eCollection 2018. Review.

15.

Non-Alcoholic Fatty Pancreas Disease (NAFPD): A Silent Spectator or the Fifth Component of Metabolic Syndrome? A Literature Review.

Romana BS, Chela H, Dailey FE, Nassir F, Tahan V.

Endocr Metab Immune Disord Drug Targets. 2018;18(6):547-554. doi: 10.2174/1871530318666180328111302. Review.

PMID:
29595117
16.

Epidemiology, determinants, and management of AIDS cholangiopathy: A review.

Naseer M, Dailey FE, Juboori AA, Samiullah S, Tahan V.

World J Gastroenterol. 2018 Feb 21;24(7):767-774. doi: 10.3748/wjg.v24.i7.767. Review.

17.

Elderly donor graft for liver transplantation: Never too late.

Chela H, Yousef MH, Albarrak AA, Romana BS, Hudhud DN, Tahan V.

World J Transplant. 2017 Dec 24;7(6):324-328. doi: 10.5500/wjt.v7.i6.324. Review.

18.

Hepatocyte transplantation: Consider infusion before incision.

Heath RD, Ertem F, Romana BS, Ibdah JA, Tahan V.

World J Transplant. 2017 Dec 24;7(6):317-323. doi: 10.5500/wjt.v7.i6.317. Review.

19.

Fatty liver without a large "belly": Magnified review of non-alcoholic fatty liver disease in non-obese patients.

Yousef MH, Al Juboori A, Albarrak AA, Ibdah JA, Tahan V.

World J Gastrointest Pathophysiol. 2017 Aug 15;8(3):100-107. doi: 10.4291/wjgp.v8.i3.100. Review.

20.

Is the 25-year hepatitis C marathon coming to an end to declare victory?

Ahmed KT, Almashhrawi AA, Ibdah JA, Tahan V.

World J Hepatol. 2017 Jul 28;9(21):921-929. doi: 10.4254/wjh.v9.i21.921. Review.

21.

Successful treatment of chronic refractory pouchitis with vedolizumab.

Mir F, Yousef MH, Partyka EK, Tahan V.

Int J Colorectal Dis. 2017 Oct;32(10):1517-1518. doi: 10.1007/s00384-017-2854-0. Epub 2017 Jul 11. No abstract available.

PMID:
28698974
22.

Coffee: The magical bean for liver diseases.

Heath RD, Brahmbhatt M, Tahan AC, Ibdah JA, Tahan V.

World J Hepatol. 2017 May 28;9(15):689-696. doi: 10.4254/wjh.v9.i15.689. Review.

23.

Synchronous Gastrointestinal Carcinoid Tumor and Colon Adenocarcinoma: Case Reports and Literature Review.

Winn JN, Sathyamurthy A, Kneib JL, Ibdah JA, Tahan V.

Am J Case Rep. 2017 Jun 6;18:626-630. Review.

24.

Sofosbuvir/velpatasvir regimen promises an effective pan-genotypic hepatitis C virus cure.

Mir F, Kahveci AS, Ibdah JA, Tahan V.

Drug Des Devel Ther. 2017 Feb 23;11:497-502. doi: 10.2147/DDDT.S130945. eCollection 2017. Review.

25.

Undigested Pills in Stool Mimicking Parasitic Infection.

Mir F, Achakzai I, Ibdah JA, Tahan V.

Case Rep Gastrointest Med. 2017;2017:3718954. doi: 10.1155/2017/3718954. Epub 2017 Jan 31.

26.
27.

Rifaximin in treatment of patients with Irritable bowel syndrome.

Romana B, Tahan V.

Turk J Gastroenterol. 2017 Jan;28(1):77-78. doi: 10.5152/tjg.2016.25122016. No abstract available.

28.

Autoimmune hemolytic anemia associated with infliximab infusion in ulcerative colitis.

Mir FA, Juboori AA, Bragg JD, Tahan V.

North Clin Istanb. 2017 Jan 11;5(1):64-66. doi: 10.14744/nci.2017.77045. eCollection 2018.

29.

Host conditioning and rejection monitoring in hepatocyte transplantation in humans.

Soltys KA, Setoyama K, Tafaleng EN, Soto Gutiérrez A, Fong J, Fukumitsu K, Nishikawa T, Nagaya M, Sada R, Haberman K, Gramignoli R, Dorko K, Tahan V, Dreyzin A, Baskin K, Crowley JJ, Quader MA, Deutsch M, Ashokkumar C, Shneider BL, Squires RH, Ranganathan S, Reyes-Mugica M, Dobrowolski SF, Mazariegos G, Elango R, Stolz DB, Strom SC, Vockley G, Roy-Chowdhury J, Cascalho M, Guha C, Sindhi R, Platt JL, Fox IJ.

J Hepatol. 2017 May;66(5):987-1000. doi: 10.1016/j.jhep.2016.12.017. Epub 2016 Dec 24.

30.

Allogenic adipose derived stem cells present a potential novel approach for treating refractory fistulizing Crohn's disease.

Heath RD, Tahan V.

Turk J Gastroenterol. 2016 Nov;27(6):568-569. doi: 10.5152/tjg.2016.160008. No abstract available.

31.

Microbiome alterations observed in liver diseases present opportunities for potential fecal transplantation.

Heath RD, Mir F, Ibdah JA, Tahan V.

Turk J Gastroenterol. 2016 Nov;27(6):495-498. doi: 10.5152/tjg.2016.160011. Review.

32.
33.

Culprit for recurrent acute gastrointestinal massive bleeding: "Small bowel Dieulafoy's lesions" - a case report and literature review.

Sathyamurthy A, Winn JN, Ibdah JA, Tahan V.

World J Gastrointest Pathophysiol. 2016 Aug 15;7(3):296-9. doi: 10.4291/wjgp.v7.i3.296.

34.

To chromo or not to chromo: That is the question!

Mir F, Tahan V.

Turk J Gastroenterol. 2016 Jul;27(4):403-4. doi: 10.5152/tjg.2016.160004. No abstract available.

35.

In a world of increasing resistance emerges a hope to eradicate Helicobacter pylori: Vonoprazan.

Nguyen Winn J, Tahan V.

Turk J Gastroenterol. 2016 May;27(3):296-7. doi: 10.5152/tjg.2016.160002. No abstract available.

36.

Extension for Community Health Outcomes-hepatitis C: Small steps carve big footprints in the allocation of scarce resources for hepatitis C virus treatment to remote developing areas.

Tahan V, Almashhrawi A, Kahveci AM, Mutrux R, Ibdah JA.

World J Hepatol. 2016 Apr 18;8(11):509-12. doi: 10.4254/wjh.v8.i11.509. Review.

37.

Sofosbuvir and Velpatasvir: A complete pan-genotypic treatment for HCV patients.

Kahveci AS, Tahan V.

Turk J Gastroenterol. 2016 Mar;27(2):205-6. doi: 10.5152/tjg.2016.160000. No abstract available.

38.

More on autoimmune hepatitis and acute hepatitis A.

Ozaras R, Tahan V, Tabak F.

Eur J Gastroenterol Hepatol. 2016 Mar;28(3):360. doi: 10.1097/MEG.0000000000000521. No abstract available.

PMID:
26825143
39.

Daclatasvir plus sofosbuvir regimen sheds promising light on future hepatitis C virus genotype 3 therapies.

Kahveci AM, Tahan V.

Turk J Gastroenterol. 2016 Jan;27(1):89-90. doi: 10.5152/tjg.2015.150012. No abstract available.

40.

Show Me ECHO-Hepatitis C: A telemedicine mentoring program for patients with hepatitis C in underserved and rural areas in Missouri as a model in developing countries.

Tahan V, Almashhrawi A, Mutrux R, Ibdah JA.

Turk J Gastroenterol. 2015 Nov;26(6):447-9. doi: 10.5152/tjg.2015.159000. Epub 2015 Oct 26. Review.

41.

Application of the LAMP Assay as a Diagnostic Technique for Rapid Identification of Thrips tabaci (Thysanoptera: Thripidae).

Fekrat L, Zaki Aghl M, Tahan V.

J Econ Entomol. 2015 Jun;108(3):1337-43. doi: 10.1093/jee/tov099. Epub 2015 May 4.

PMID:
26470262
42.

Alcohol is not Safe even at Light Amounts.

Tahan AC, Tahan V.

Balkan Med J. 2015 Apr;32(2):239. doi: 10.5152/balkanmedj.2015.150853. Epub 2015 Apr 1. No abstract available.

43.

Hepatic apoptotic markers are not predictors for the virological response to interferon-based therapy in chronic hepatitis C patients.

Ozaras R, Tahan V, Ozbay G, Ozturk R, Yenice N, Celikel ÇA, Midilli K, Gucin Z, Fincanci M, Tozun N, Senturk H, Osme A, Tabak F, Mert A.

Eur J Gastroenterol Hepatol. 2015 Sep;27(9):1057-62. doi: 10.1097/MEG.0000000000000397.

PMID:
26011229
44.

"If a fake friend stays in your vodkabulary as a stem friend": granulocyte colony-stimulating factor promoted stem cell therapy in severe alcoholic hepatitis.

Tahan AC, Tahan V.

Turk J Gastroenterol. 2014 Dec;25(6):748-9. doi: 10.5152/tjg.2014.0060. No abstract available.

45.

Placental amniotic epithelial cells and their therapeutic potential in liver diseases.

Tahan AC, Tahan V.

Front Med (Lausanne). 2014 Dec 8;1:48. doi: 10.3389/fmed.2014.00048. eCollection 2014. Review.

46.

"Actions speak louder than words": adenoma detection rates inversely associated with colorectal cancer and mortality.

Tahan G, Tahan V.

Turk J Gastroenterol. 2014 Oct;25(5):602. doi: 10.5152/tjg.2014.0050. No abstract available.

47.

"Could a cup of coffee a day keep the liver doctor away?": One cup or two or more cups of coffee per day reduces the risk of death from cirrhosis.

Tahan AC, Tahan V.

Turk J Gastroenterol. 2014 Aug;25(4):470-1. doi: 10.5152/tjg.2014.0030. No abstract available.

48.

"Old classic cars" are hidden treasures: colorectal cancer screening should be considered in unscreened persons over age 75.

Tahan G, Tahan V.

Turk J Gastroenterol. 2014 Jun;25(3):349-50. doi: 10.5152/tjg.2014.0015. No abstract available.

49.
50.

Once spontaneous bacterial peritonitis develops, discontinue nonselective beta blockers permanently. A proposed practice change update.

Tahan V.

Turk J Gastroenterol. 2014 Apr;25(2):232. doi: 10.5152/tjg.2014.0010. No abstract available.

Supplemental Content

Support Center